A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies.
There has been great interest in genetic risk prediction using risk scores in recent years, however, the utility of scores developed in European populations and later applied to non-European populations has not been successful. The goal of this study was to create a methylation risk score (MRS) for...
Enregistré dans:
| Auteurs principaux: | Bertha A Hidalgo, Bre Minniefield, Amit Patki, Rikki Tanner, Minoo Bagheri, Hemant K Tiwari, Donna K Arnett, Marguerite Ryan Irvin |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/497a6248df3448a8a7ae3bc451ee5293 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
par: Bertha A. Hidalgo, et autres
Publié: (2021) -
AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.
par: Sarah S Knox, et autres
Publié: (2010) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
par: Chloe Goldsmith, et autres
Publié: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
par: Chen W, et autres
Publié: (2021) -
Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
par: Marguerite R. Irvin, et autres
Publié: (2021)